SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-16-765208
Filing Date
2016-11-10
Accepted
2016-11-10 08:07:26
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-3 d264849ds3.htm S-3 394604
2 EX-1.2 d264849dex12.htm EX-1.2 178528
3 EX-4.1 d264849dex41.htm EX-4.1 253463
4 EX-4.2 d264849dex42.htm EX-4.2 257067
5 EX-5.1 d264849dex51.htm EX-5.1 12924
6 EX-5.2 d264849dex52.htm EX-5.2 7094
7 EX-12.1 d264849dex121.htm EX-12.1 27949
8 EX-23.1 d264849dex231.htm EX-23.1 1406
9 GRAPHIC g264849bc_pg001.jpg GRAPHIC 22721
10 GRAPHIC g264849cov_pg001.jpg GRAPHIC 23181
11 GRAPHIC g264849supbc_pg001a.jpg GRAPHIC 22411
12 GRAPHIC g264849supbc_pg001b.jpg GRAPHIC 17987
13 GRAPHIC g264849supcov_pg001a.jpg GRAPHIC 22696
14 GRAPHIC g264849supcov_pg001b.jpg GRAPHIC 18297
15 GRAPHIC g264849suptx_pg001.jpg GRAPHIC 62863
  Complete submission text file 0001193125-16-765208.txt   1396999
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Filer) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-214539 | Film No.: 161986059
SIC: 2836 Biological Products, (No Diagnostic Substances)